Applied Genetic Technologies (AGTC) News Today → The #1 Investment of the Decade… (From Porter & Company) (Ad) Free AGTC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGenetic Technologies Limited (GENE)finance.yahoo.com - April 28 at 10:43 PMDry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsightfinance.yahoo.com - April 22 at 5:39 PMBeacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosafinance.yahoo.com - February 8 at 10:31 AMMetagenomi Technologies Files for Initial Public Offeringmarketwatch.com - January 5 at 7:01 PMA new mathematical language for biological networksmsn.com - December 18 at 1:59 PMGenetic Technologies (GENE) Earnings Dates & Reportsinvesting.com - October 23 at 1:15 PMSyncona launches new gene therapy company with GBP96 million fundinglse.co.uk - June 12 at 12:23 PMNew AI tool searches genetic haystacks to find disease-causing variantsmsn.com - June 1 at 7:55 PMSania Therapeutics launches to advance novel medicines for neural circuit dysfunctionuk.finance.yahoo.com - May 17 at 3:17 AMApplied Technology Centerusnews.com - May 1 at 10:38 PMAAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the Domainfinance.yahoo.com - April 27 at 1:53 PMWorld-first technology from biomodal enables reading of genetic and epigenetic information using existing sequencersmsn.com - April 21 at 10:50 AMElephant in the dining room: Startup creates mammoth meatballnbcnews.com - April 1 at 5:47 AMGenetic control of metabolismbbc.co.uk - March 22 at 1:57 PMGenetic testing and cystic fibrosisbbc.co.uk - March 16 at 10:23 AMRallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officeryahoo.com - January 31 at 6:11 PMApplied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Dealthestreet.com - January 5 at 2:36 PMmarketbeat.com - December 1 at 6:04 AM*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*finance.yahoo.com - November 28 at 11:41 AM*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*finance.yahoo.com - November 22 at 6:46 PMApplied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022finance.yahoo.com - November 15 at 12:19 AMApplied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022finance.yahoo.com - November 3 at 10:29 AMFlorida investment firm looks to take Cambridge gene therapy startup privatefinance.yahoo.com - October 25 at 10:08 AMSyncona to acquire retinal therapy firm Applied Genetic Technologieslse.co.uk - October 24 at 4:37 AMSyncona to Acquire Applied Genetic Technologies Corporationfinance.yahoo.com - October 23 at 10:30 PMiNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesismarkets.businessinsider.com - October 18 at 1:43 AMHC Wainwright & Co. Maintains Buy Rating for Applied Genetic: Here's What You Need To Knowmsn.com - September 30 at 1:19 PMApplied Genetic Technologies (NASDAQ: AGTC)fool.com - September 23 at 11:36 PMApplied Genetic Technologies Corpreuters.com - August 29 at 8:36 PMAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facilityfinance.yahoo.com - July 26 at 8:48 AMAGTC Announces Pricing of $10 Million Underwritten Public Offeringfinance.yahoo.com - July 13 at 2:20 AMAGTC Announces Proposed Underwritten Public Offeringfinance.yahoo.com - July 12 at 4:19 PMAGTC Announces Key Appointments to Leadership Teamfinance.yahoo.com - June 8 at 10:24 AMAGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meetingfinance.yahoo.com - June 6 at 11:37 AMAGTC to Present at the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 18 at 10:11 AMAGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosafinance.yahoo.com - May 16 at 9:03 PMAGTC Hosts Topping Off Ceremony for Gene Therapy Manufacturing Facility to Celebrate the Building’s Structural Completionfinance.yahoo.com - May 10 at 12:13 PMPositive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meetingfinance.yahoo.com - May 4 at 1:14 PMAGTC to Present Preclinical Research Supporting Gene Therapytmcnet.com - May 2 at 7:24 PMAGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at the 25th Annual Meeting of the American Society of Gene & Cell Therapyfinance.yahoo.com - May 2 at 7:24 PMAGTC to Present at Cell & Gene Meeting on the Mediterraneanfinance.yahoo.com - April 14 at 1:20 PMAGTC Announces Pricing of Public Offering of Common Stockfinance.yahoo.com - March 22 at 12:11 PMAGTC to Participate in Upcoming Investor Conferencesfinance.yahoo.com - March 8 at 6:31 PMAGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022finance.yahoo.com - February 7 at 8:05 AMAGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa (XLRP)finance.yahoo.com - January 11 at 8:50 AMAGTC to Participate in the H.C. Wainwright BioConnect 2022 Conferencefinance.yahoo.com - January 4 at 10:14 AMApplied Genetic Technologies Corp Shares Approach 52-Week Low - Market Movernasdaq.com - December 29 at 5:30 AMApplied Genetic Technologies Corp Shares Approach 52-Week Low - Market Movernasdaq.com - December 29 at 5:30 AMApplied Genetic Technologies (NASDAQ:AGTC) Upgraded at Zacks Investment Researchmarketbeat.com - December 10 at 4:47 PMAGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directorsfinance.yahoo.com - December 6 at 8:15 AM Get Applied Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New York goes dark, then America. (Ad)Artificial intelligence is about to trigger a shocking new crisis in New York. Experts warn it could be “the next 9/11” and while New York will be ground zero for this looming catastrophe, it will not be the only state impacted. This crisis could affect 233 million Americans starting at any moment from now. Click here for the full story. AGTC Media Mentions By Week AGTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGTC News Sentiment▼0.340.40▲Average Medical News Sentiment AGTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGTC Articles This Week▼00▲AGTC Articles Average Week Get Applied Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Brainstorm Cell Therapeutics News Pluri News Achilles Therapeutics News ZIVO Bioscience News AIM ImmunoTech News IN8bio News Protara Therapeutics News MiNK Therapeutics News Aptose Biosciences News Surrozen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGTC) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersBanking Apocalypse Ahead: Secure Your Savings Today!Weiss RatingsMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceMost important medical advance in 100 yearsThe Oxford Club#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Genetic Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
